Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year ...

A study that looks into the potential of wearables to non-invasively measure blood glucose has come up with promising results ...

First Update in Nearly 10 Years by FITTER Forward Initiative Sets Out to Transform Insulin Injection Technique EducationPARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") ...

Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.

The global diabetes care devices market is poised for substantial expansion, with projections indicating a rise from USD 64.5 billion in 2024 to an impressive USD 117.7 billion by 2034. The market’s ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Mumbai: A pet dog , Nikki, with uncontrolled blood sugar levels just got a tech device to keep track of his glucose levels. The 3-year-old male pug has been wearing the 'continuous glucose monitor ...

Scientists at the Łódź University of Technology in central Poland have developed a new light-based therapy device designed to support home treatment of diabetic foot syndrome, a serious ...

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts warn.